Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Mohey

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort StudyAmrit Kaur Virdee, Fredrikke Christie Knudtzen, Josep M Llibre, et al.
BMC Infectious Diseases|January 10, 2021
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort studyJon Gitz Holler, Robert Eriksson, Tomas Østergaard Jensen, et al.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Nature Medicine|October 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trialJesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2024
Risk of Tuberculosis After Achieving HIV Virological Suppression on Antiretroviral Therapy: A Danish Nationwide Prospective Cohort StudyAmrit Kaur Virdee, Fredrikke Christie Knudtzen, Josep M Llibre, et al.
BMC Infectious Diseases|January 10, 2021
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort studyJon Gitz Holler, Robert Eriksson, Tomas Østergaard Jensen, et al.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Nature Medicine|October 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trialJesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert, et al.
Pageof 3